Navigation Links
FDA Accepts Tasimelteon New Drug Application For Priority Review In The Treatment Of Non-24-Hour Disorder In The Totally Blind
Date:7/29/2013

s adverse events were deemed unrelated to study drug and the rates between tasimelteon and placebo treated patients were similar (1.6%, 1.5%).

About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda, please visit http://www.vandapharma.com.  

Company Contact:
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

Media Contact:
Laney Landsman
Assistant Vice President
Makovsky
(212) 508-9643
llandsman@makovsky.com

CAUTIONARY NOTE REGARDING FORWWARD LOOKING STATEMENTS
Various statements in this release are "forward-looking statements" under the securities laws.  Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "project," "target," "goal," "likely," "will," "would," and "could," or the negative of these terms and similar expressions or words, identify forward-looking statements.  Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties.  Important factors that could cause actual results to differ materially from those reflected in the company's forward-looking statements include, among others: Vanda's failure to obtain, or any delay in obtaining, regulatory approval for tasimelteon for the treatment of Non-24-Hour Disorder or to comply with ongoing regulatory requirements and other factors that are described in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
2. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
3. FDA Accepts Novens NDA For An Investigational Nonhormonal Therapy For Menopausal Vasomotor Symptoms
4. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
5. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
6. Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
7. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
8. Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
9. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
10. EPGL Medical Invents Self Powered Contact Lenses for Medical and Consumer Applications
11. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Calif. , May 28, 2015  IRIDEX Corporation (NASDAQ: ... Chief Financial Officer James H. Mackaness is scheduled ... 3, 2015, at 9:00 am PT in Los ... the presentation may be accessed on the Event Calendar of ...  A replay of the webcast will be available shortly after ...
(Date:5/28/2015)... 2015 Research and ... of the  "North America Ultrasound Devices Market ... 2019)"  report to their offering.  ... a type of imaging. It uses high-frequency ... and structures inside the body. Health care ...
(Date:5/28/2015)... , May 28, 2015   Mast ... biopharmaceutical company leveraging its molecular adhesion and sealant ... sickle cell disease, heart failure, and arterial disease, ... from the Company,s Board of Directors. Mr. Lief ... of interest given his role as President and ...
Breaking Medicine Technology:North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4
... April 8, 2011 ImageXpres Corporation (Pink Sheets: ... financial results and annual report that highlighted the key ... 31, 2010. Overall financial results for 2010 demonstrated significant ... and net income of $109,033 for all of 2010, ...
... 8, 2011 Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ... of drugs for the treatment of human viral diseases, today ... 18,310,000 shares of its common stock at a public offering ... being sold by Idenix. The offering is expected to close ...
Cached Medicine Technology:ImageXpres Posts OTC Markets 2010 Annual Report 2ImageXpres Posts OTC Markets 2010 Annual Report 3Idenix Pharmaceuticals Prices Public Offering of Common Stock 2
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe is ... Joint Fluid Therapy (JFT) at their clinics in Orange ... injectable treatment that assists in diminishing pain for patients ... Dr. Stanley Katz and Dr. Neil Katz of Healthpointe. ... sodium hyaluronate (also known as hyaluronic acid) a natural ...
(Date:5/29/2015)... Clarkston, Metamora, Michigan (PRWEB) May 29, 2015 ... vulvar region and can cause significant physical, sexual, and ... major life altering disorder of Vulvodynia. The actual diagnosis ... Women’s Excellence in Endometriosis, they realize that this problem ... patient is experiencing any of these symptoms, they need ...
(Date:5/29/2015)... May 29, 2015 The popular all-natural ... their rewards based L-Style Select Program that gives bonuses ... is limited to only 100 members per year, lucky ... one on one with fitness experts at Nuretix Research, ... to them provided that they attain and maintain their ...
(Date:5/29/2015)... Health DataPalooza is a national conference that brings ... the most effective and innovative ways to use open ... by the Health Data Consortium, which is a collaboration ... develop the use of open healthcare data. Within ... in on how to actually put the ideas into ...
(Date:5/29/2015)... 29, 2015 External Counterpulsation, also known as ... treatment for patients. The Heart Fit Clinic is the first ... a raving review from patients who are now completing treatment. ... underwent 35 treatments of ECP treatment and received great results. ... Not only does the clinic perform this non-surgical treatment for ...
Breaking Medicine News(10 mins):Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2Health News:Liporidex, a Sports Nutrition Supplement Brand, Is Searching For Members For Their Exclusive L-Style Select Program Which Rewards Members For Their Achievements 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2
... ... supplements, announces the release of their new Lycopene Omega-3 Super Formula. , ... (PRWEB) February 1, 2010 -- ... their new Lycopene Omega-3 Super Formula ., , ,The new formula further strengthens ...
... , AURORA, Colo. , Feb. 1 ... (CID4) launches this month with a statewide "Call for Proposals" from ... active management.  The announcement is made by Kevin M. Smith ... 20,000 good-paying jobs in Colorado , the life sciences industry ...
... Little difference in survival found 10 years after therapies, ... Long-term survival rates are similar for leukemia patients who,ve ... marrow transplants, a new European study says. , The ... PBSC or bone marrow transplants from a matched sibling ...
... Third Season Features New Dating ... (PRWEB) January 29, 2010 ... game show in which three single women or men will prepare a dish to be selected ... , , , ,Cooking for Bachelors, dubbed by Channel12News and the Brooklyn Paper as the show ...
... ... , ... 2010 -- Canadian NGO, The Nancy Nielsen Charitable Foundation, and its Kenyan agent, Cherish ... a demonstration run/walk to protest FGM in the Transmara. The 4 kilometer event will ...
... ... Nutrition™ ( http://www.kardeanutrition.com ) is pleased to announce that it has teamed with ... Cardiologist®, ( http://www.thecookingcardiologist.com/ ) to develop an integrated nutritional approach that advances cardiovascular ... ...
Cached Medicine News:Health News:Purity Products Releases Their Next Generation Lycopene Omega-3 Super Formula 2Health News:The Colorado Institute for Drug, Device and Diagnostic Development Launches With a Statewide 'Call for Proposals' From Life Science Technologies in Need of Funding and Active Management 2Health News:Stem Cell, Bone Marrow Transplants Both Benefit Leukemia Patients 2Health News:Cooking For Bachelors Seeks Singles Cooking For Love 2Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 2Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 3Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 4Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 5Health News:Kardea Nutrition & The Cooking Cardiologist Join to Create Gourmet System for Heart Health 2Health News:Kardea Nutrition & The Cooking Cardiologist Join to Create Gourmet System for Heart Health 3
XL STABI Hydrophilic Acrylic Lens....
TRIPODE Hydrophilic Acrylic Lens....
Biocryl™ Acrylic Foldable Lens....
The STAAR ELASTIMIDE lens, combines the best of foldable lens technology with traditional design. This lens contains a cast-molded, silicone optic with modified Polyimide haptics....
Medicine Products: